MicroStrategy
MSTR
Adobe
ADBE
賽富時
CRM
蘋果
AAPL
Meritage Homes
MTH
美股市場個股詳情
ENGN enGene Holdings
- 5.830
- -0.130-2.18%
收盤價 12/20 16:00 (美東)
2.97億總市值-5.39市盈率TTM
6.540最高價5.600最低價9.92萬股成交量6.540今開5.960昨收58.41萬成交額0.34%換手率虧損市盈率(靜)5097.67萬總股本18.40052周最高1.09市淨率1.71億流通值4.42052周最低--股息TTM2935.90萬流通股47.170歷史最高--股息率TTM15.77%振幅4.420歷史最低5.890平均價1股每手
關於enGene Holdings公司
enGene Holdings Inc .是一家臨牀階段的生物技術公司，致力於開發基因療法以改善患者的生活。該公司正在開發基於其新型和專有的雙衍生殼聚糖(DDX)基因遞送平臺的非病毒基因療法，該平臺可以將多個基因貨物直接局部遞送到粘膜組織和其他器官。
公司介紹
公司代碼ENGN
公司名稱enGene Holdings
上市日期2022/02/01
成立日期2023
CEOMr. Ronald H.W. Cooper
所屬市場納斯達克
員工數量33
年結日10-31
公司地址4868 Rue Levy,Suite 220
城市Saint-Laurent
省份魁北克省
國家加拿大
郵編H4R 2P1
電話1-514-332-4888
董事高管
- 姓名
- 職務
- 年薪
- Ronald H.W. Cooper
- President, Chief Executive Officer and Director
- --
- Dr. Anthony Tzeyew Cheung, PhD
- Chief Scientific Officer
- --
- Dr. Alexander Julian Nichols
- Chief Strategy Officer and Chief Operations Officer of Company and EnGene Inc
- 97.00萬
- Dr. Raj Som Pruthi, M.D.
- Chief Medical Officer
- --
- Joan Connolly
- Chief Technology Officer
- --
- Ryan Daws
- Chief Financial Officer, Head of Business Development and Principal Accounting Officer
- --
- Dr. Richard M. Glickman,L.L.D.
- Independent Director; Chairman of the Board of EnGene Inc
- --
- Lota S. Zoth, C.P.A.
- Director
- --
- Gerald Brunk
- Independent Director
- --
- Paul J. Hastings
- Independent Director
- --
- Dr. Jasper Bos, PhD
- Independent Director
- --
- Wouter Joustra
- Independent Director
- --